In summary, our study demonstrated that blocking TIGIT effectively enhances the anti-tumor effect of CAR-T cells, thereby suggesting a promising strategy for the treatment of solid tumors by combining CAR-T cells with immune checkpoint blockages. The gene discussed is TIGIT; the disease is neoplasm.